These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12926045)

  • 1. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level.
    Iczkowski KA; Bai S; Pantazis CG
    Anticancer Res; 2003; 23(4):3129-40. PubMed ID: 12926045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
    Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
    Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient expression of CD44 variant isoforms in the ontogeny of the rat: ectoderm-, endoderm- and mesoderm-derived cells express different exon combinations.
    Weber B; Rösel M; Arch R; Möller P; Zöller M
    Differentiation; 1996 Mar; 60(1):17-29. PubMed ID: 8935925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD44 isoforms in human prostate tumor cell lines.
    Stevens JW; Palechek PL; Griebling TL; Midura RJ; Rokhlin OW; Cohen MB
    Prostate; 1996 Mar; 28(3):153-61. PubMed ID: 8628718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
    Ermak G; Jennings T; Robinson L; Ross JS; Figge J
    Cancer Res; 1996 Mar; 56(5):1037-42. PubMed ID: 8640758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells.
    Liu NP; Roberts WL; Hale LP; Levesque MC; Patel DD; Lu CL; Jaffe GJ
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2027-37. PubMed ID: 9331266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 variant isoforms in malignant melanoma.
    Seiter S; Schadendorf D; Herrmann K; Schneider M; Rösel M; Arch R; Tilgen W; Zöller M
    Clin Cancer Res; 1996 Mar; 2(3):447-56. PubMed ID: 9816190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
    Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
    Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.
    Kallakury BV; Yang F; Figge J; Smith KE; Kausik SJ; Tacy NJ; Fisher HA; Kaufman R; Figge H; Ross JS
    Cancer; 1996 Oct; 78(7):1461-9. PubMed ID: 8839552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 Expression in Benign and Neoplastic Human Prostates.
    Dhir R; Gau JT; Krill D; Bastacky S; Bahnson RR; Cooper DL; Becich MJ
    Mol Diagn; 1997 Sep; 2(3):197-204. PubMed ID: 10462610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive loss of CD44 gene expression in invasive bladder cancer.
    Sugino T; Gorham H; Yoshida K; Bolodeoku J; Nargund V; Cranston D; Goodison S; Tarin D
    Am J Pathol; 1996 Sep; 149(3):873-82. PubMed ID: 8780391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
    Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
    Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
    Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
    Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia.
    Nägler DK; Krüger S; Kellner A; Ziomek E; Menard R; Buhtz P; Krams M; Roessner A; Kellner U
    Prostate; 2004 Jul; 60(2):109-19. PubMed ID: 15162377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine calcitonin in prostate cancer is linked to CD44 variant expression and invasion.
    Iczkowski KA; Omara-Opyene AL; Kulkarni TR; Pansara M; Shah GV
    Anticancer Res; 2005; 25(3B):2075-83. PubMed ID: 16158948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44 splice variants in colorectal cancer.
    Wong LS; Cantrill JE; Morris AG; Fraser IA
    Br J Surg; 1997 Mar; 84(3):363-7. PubMed ID: 9117309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells.
    Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M
    Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of CD44 adhesion molecule in testicular germ cell tumors and normal testes.
    Miyake H; Hara I; Yamanaka K; Gohji K; Arakawa S; Kamidono S
    Am J Pathol; 1998 May; 152(5):1157-60. PubMed ID: 9588883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.